Published in Transplantation on November 15, 2008
Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs (2011) 1.24
Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol (2013) 0.86
mTOR inhibitors in pediatric kidney transplantation. Pediatr Nephrol (2013) 0.86
Long-term side effects of treatment with mTOR inhibitors in children after renal transplantation. Pediatr Nephrol (2013) 0.79
Biologics in renal transplantation. Pediatr Nephrol (2014) 0.75
How randomised trials have improved the care of children with kidney disease. Pediatr Nephrol (2016) 0.75
Strict blood-pressure control and progression of renal failure in children. N Engl J Med (2009) 5.71
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet (2006) 5.36
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med (2002) 5.34
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med (2011) 3.84
Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat Genet (2011) 3.06
Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science (2003) 3.00
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis (2002) 2.89
IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol (2007) 2.83
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet (2011) 2.82
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet (2007) 2.79
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. Am J Hum Genet (2008) 2.74
Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet (2004) 2.67
Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum (2013) 2.60
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis (2005) 2.50
Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 2.47
Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res (2006) 2.46
SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A (2004) 2.41
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34
Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension (2013) 2.31
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol (2008) 2.30
Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med (2003) 2.28
Day- and night-time blood pressure elevation in children with higher grades of renal scarring. J Pediatr (2003) 2.27
Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis (2008) 2.24
VirB11 ATPases are dynamic hexameric assemblies: new insights into bacterial type IV secretion. EMBO J (2003) 2.23
Chronic kidney disease in adolescent and adult patients with phenylketonuria. J Inherit Metab Dis (2012) 2.15
A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol (2003) 2.11
Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol (2006) 2.02
Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int (2009) 2.01
Hyperoxaluria: a gut-kidney axis? Kidney Int (2011) 1.90
History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol (2010) 1.84
Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog (2009) 1.82
Dent Disease with mutations in OCRL1. Am J Hum Genet (2004) 1.81
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med (2010) 1.80
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis (2012) 1.79
Nephrocalcinosis and urolithiasis in children. Kidney Int (2011) 1.77
A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol (2003) 1.77
Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol (2010) 1.76
Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy. J Med Genet (2010) 1.76
Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol (2004) 1.75
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol (2012) 1.75
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest (2013) 1.74
Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens (2005) 1.73
Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One (2007) 1.73
Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm. Kidney Int (2009) 1.70
Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood (2007) 1.70
Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol (2003) 1.69
KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J Clin Invest (2015) 1.69
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant (2006) 1.67
Platelet-associated complement factor H in healthy persons and patients with atypical HUS. Blood (2009) 1.67
Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum Mutat (2010) 1.67
Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation (2009) 1.63
C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int (2008) 1.61
Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc (2007) 1.60
Takayasu arteritis in children and adolescents. Rheumatology (Oxford) (2010) 1.58
Labelling of cells with quantum dots. Nanotechnology (2005) 1.57
Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant (2008) 1.56
Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int (2005) 1.55
Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol (2008) 1.52
Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis (2011) 1.51
Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol (2003) 1.51
Congenital versus acquired solitary kidney: is the difference relevant? Nephrol Dial Transplant (2010) 1.50
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant (2012) 1.48
A novel transfecting peptide comprising a tetrameric nuclear localization sequence. J Mol Med (Berl) (2003) 1.48
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol (2002) 1.48
Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med (2004) 1.48
Percutaneous endoscopic gastrostomy in children on peritoneal dialysis. Perit Dial Int (2006) 1.47
A novel TRPC6 mutation that causes childhood FSGS. PLoS One (2009) 1.47
Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int (2004) 1.46
Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem (2003) 1.45
Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. Nephrol Dial Transplant (2012) 1.44
Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med (2011) 1.43
Which creatinine and cystatin C equations can be reliably used in children? Clin J Am Soc Nephrol (2010) 1.43
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release (2009) 1.42
Latex allergy in children with urological malformation and chronic renal failure. J Urol (2004) 1.42
The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation. Nephrol Dial Transplant (2004) 1.42
The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab (2010) 1.42
Urinary proteome analysis to exclude severe vesicoureteral reflux. Pediatrics (2012) 1.42
Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria. J Transl Med (2013) 1.42
Virtual slides: high-quality demand, physical limitations, and affordability. Hum Pathol (2003) 1.42
Hyperuricemia after liver transplantation in children. Pediatr Transplant (2008) 1.41